Log In
BCIQ
Print this Print this
 

Natroba, spinosad

  Manage Alerts
Collapse Summary General Information
Company SePRO Corp.
DescriptionTopical formulation containing 0.9% spinosad
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationLice
Indication DetailsTreat head lice
Regulatory Designation
PartnerPernix Therapeutics Holdings Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/17/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today